Abstract

Although increased patenting has accompanied the development of antivirals as in vivo therapeutics, ongoing US litigation reflects concerns regarding their patentability.

1. Deborah L. Lu, Angela M. Collison and Thomas J. Kowalski are at Frommer Lawrence & Haug LLP, 745 Fifth Avenue, New York, New York 10151, USA. e-mail: tkowalski@flhlaw.com

NPG Journals

by Subject Area

• Chemistry

  • Chemistry
  • Drug discovery
  • Biotechnology
  • Materials
  • Methods & Protocols

• Clinical Practice & Research

  • Cancer
  • Cardiovascular medicine
  • Dentistry
  • Endocrinology
  • Gastroenterology & Hepatology
  • Methods & Protocols
  • Pathology & Pathobiology
  • Urology

• Earth & Environment

  • Earth sciences
  • Evolution & Ecology

• Life sciences

  • Biotechnology
  • Cancer
  • Development
  • Drug discovery
  • Evolution & Ecology
  • Genetics
  • Immunology
  • Medical research
  • Methods & Protocols
  • Microbiology
  • Molecular cell biology
  • Neuroscience
  • Pharmacology
  • Systems biology

• Physical sciences

  • Physics
  • Materials

by A - Z Index